Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
17.6% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
20
users have followed this narrative
New
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.1% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
17
users have liked this narrative
7
users have commented on this narrative
24
users have followed this narrative
9 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
4.7% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
21
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
47.4% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
14
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Medical Properties Trust
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
International Healthcare Markets Will Benefit From Demographic Trends
Key Takeaways Growing rental income and stronger operator performance are driving revenue and supporting steady earnings growth across the global hospital portfolio. International expansion and access to affordable capital are enhancing portfolio diversification and enabling sustainable, long-term revenue streams.
View narrative
US$4.86
FV
10.9% undervalued
intrinsic discount
3.12%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
1
users have commented on this narrative
106
users have followed this narrative
7 days ago
author updated this narrative
Mercury Systems
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
US And European Defense Trends Will Drive Transformation
Key Takeaways Alignment with global defense modernization and digitization trends is driving higher-margin contracts, improved backlog quality, and greater revenue visibility. Operational enhancements and R&D investments support margin expansion and a shift toward a more predictable, higher-value earnings model.
View narrative
US$65.43
FV
1.4% undervalued
intrinsic discount
6.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
7 days ago
author updated this narrative
Alignment Healthcare
AN
AnalystConsensusTarget
Consensus Narrative from 10 Analysts
Digital Health And Automation Will Support Medicare Expansion
Key Takeaways Proprietary technology and automation reduce costs, boost scalability, and support sustained margin and earnings growth alongside durable clinical and operational advantages. Demographic trends and geographic expansion fuel long-term membership and revenue growth, while industry-leading performance strengthens competitive positioning and future profitability.
View narrative
US$18.90
FV
20.5% undervalued
intrinsic discount
26.49%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
7 days ago
author updated this narrative
LifeStance Health Group
AN
AnalystConsensusTarget
Consensus Narrative from 7 Analysts
US Mental Health Demand And AI Will Expand Care Access
Key Takeaways Rising demand, favorable insurance trends, and policy support are set to drive predictable growth and revenue for LifeStance. Technology investment, clinician productivity initiatives, and expansion plans are positioned to scale profits and boost long-term margins.
View narrative
US$8.43
FV
36.5% undervalued
intrinsic discount
14.59%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
4
users have followed this narrative
7 days ago
author updated this narrative
Ambarella
AN
AnalystConsensusTarget
Consensus Narrative from 12 Analysts
Leveraging Edge AI Processing With DeepSeek-R1 Will Unlock New Applications
Key Takeaways Ambarella's focus on edge AI, innovative SoCs, and automotive market expansion is driving potential revenue and earnings growth. Commitment to advanced technologies and efficiency improvements positions Ambarella for margin expansion and future growth.
View narrative
US$77.72
FV
15.6% undervalued
intrinsic discount
15.55%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
7 days ago
author updated this narrative
Rumble
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
International Partnerships And Cloud Investments Will Expand Global Reach
Key Takeaways New product launches and partnerships diversify revenue streams, expand monetization, and reduce reliance on a niche user base. International expansion and investment in AI infrastructure position the company for user growth, higher margins, and long-term earnings strength.
View narrative
US$14.50
FV
47.6% undervalued
intrinsic discount
23.13%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
0
users have commented on this narrative
13
users have followed this narrative
7 days ago
author updated this narrative
Ultragenyx Pharmaceutical
AN
AnalystConsensusTarget
Consensus Narrative from 20 Analysts
Advancements In Genomics And Rare Therapies Will Expand Prospects
Key Takeaways Expansion of the rare disease market and favorable regulatory environment are driving strong revenue growth and pricing power for Ultragenyx's therapies. Advancing late-stage pipeline, successful product launches, and gene therapy innovation position the company for diversified growth and improved profitability.
View narrative
US$86.05
FV
65.9% undervalued
intrinsic discount
31.98%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
2
users have followed this narrative
7 days ago
author updated this narrative
Telephone and Data Systems
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
Fiber Expansion And Rural Broadband Will Drive Enduring Progress
Key Takeaways Divesting wireless and spectrum assets has enabled strategic focus on fiber and towers, creating flexibility for expansion, M&A, and shareholder value initiatives. Expanding rural broadband through government programs and in-house capabilities is driving customer growth, market penetration, and sustained service revenue gains.
View narrative
US$52.00
FV
24.9% undervalued
intrinsic discount
-1.72%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
3
users have followed this narrative
7 days ago
author updated this narrative
Liberty Global
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts
European Broadband Upgrades And Fiber Expansion Will Unlock Future Value
Key Takeaways Accelerated network upgrades, bundled service strategies, and asset optimization aim to strengthen competitive positioning, stabilize revenue, and support margin expansion. Corporate simplification, digital transformation, and potential asset spin-offs target improved efficiency and unlocking shareholder value.
View narrative
US$14.93
FV
24.1% undervalued
intrinsic discount
1.10%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
7 days ago
author updated this narrative
Value any company in seconds
Popular companies